Medical Cannabis Moves Forward, Recreational Stays Stuck: Tax and Compliance Takeaways
At the end of April 2026, the federal government took a major step by moving FDA‑approved marijuana products and marijuana sold under qualifying state medical marijuana licenses from Schedule I to Schedule III of the Controlled Substances Act. This change recognizes accepted medical use and makes it easier to conduct clinical research, but it does
